These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15211883)

  • 21. Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer.
    Shibuya K; Oya N; Fujii T; Doi R; Nakamura A; Matsuo Y; Mitsumori M; Hiraoka M
    Am J Clin Oncol; 2011 Apr; 34(2):115-9. PubMed ID: 20065850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.
    Igarashi H; Ito T; Kawabe K; Hisano T; Arita Y; Kaku T; Takayanagi R
    World J Gastroenterol; 2008 Sep; 14(34):5311-5. PubMed ID: 18785284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.
    Autorino R; Mattiucci GC; Ardito F; Balducci M; Deodato F; Macchia G; Mantini G; Perri V; Tringali A; Gambacorta MA; Tagliaferri L; Giuliante F; Morganti AG; Valentini V
    Anticancer Res; 2016 Feb; 36(2):737-40. PubMed ID: 26851032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
    Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
    J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-dose gemcitabine concurrent with radiation therapy for locally advanced pancreatic carcinoma].
    Baba H; Kurata M; Tsuruta K; Okamoto A; Karasawa K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1863-5. PubMed ID: 17212129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
    McGinn CJ; Lawrence TS; Zalupski MM
    Cancer; 2002 Aug; 95(4 Suppl):933-40. PubMed ID: 12209674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer.
    Hunter KU; Feng FY; Griffith KA; Francis IR; Lawrence TS; Desai S; Murphy JD; Zalupski MM; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):921-6. PubMed ID: 22208966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.
    Okusaka T; Ito Y; Ueno H; Ikeda M; Takezako Y; Morizane C; Kagami Y; Ikeda H
    Br J Cancer; 2004 Aug; 91(4):673-7. PubMed ID: 15226765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.
    Budiharto T; Haustermans K; Van Cutsem E; Van Steenbergen W; Topal B; Aerts R; Ectors N; Bielen D; Vanbeckevoort D; Goethals L; Verslype C
    Radiat Oncol; 2008 Sep; 3():30. PubMed ID: 18808686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer.
    Furuse J; Ishii H; Kawashima M; Nagase M; Nihei K; Nakachi K; Ogino T; Yoshino M
    Hepatogastroenterology; 2007; 54(77):1575-8. PubMed ID: 17708303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
    Crane CH; Antolak JA; Rosen II; Forster KM; Evans DB; Janjan NA; Charnsangavej C; Pisters PW; Lenzi R; Papagikos MA; Wolff RA
    Int J Gastrointest Cancer; 2001; 30(3):123-32. PubMed ID: 12540024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
    Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
    Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer.
    Poggi MM; Kroog GS; Russo A; Muir C; Cook J; Smith J; Mitchell JB; Herscher LL
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):670-6. PubMed ID: 12377317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
    Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
    Gurka MK; Collins SP; Slack R; Tse G; Charabaty A; Ley L; Berzcel L; Lei S; Suy S; Haddad N; Jha R; Johnson CD; Jackson P; Marshall JL; Pishvaian MJ
    Radiat Oncol; 2013 Mar; 8():44. PubMed ID: 23452509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.
    Epelbaum R; Rosenblatt E; Nasrallah S; Faraggi D; Gaitini D; Mizrahi S; Kuten A
    J Surg Oncol; 2002 Nov; 81(3):138-43. PubMed ID: 12407726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.
    Suh WW; Schott AF; Hayman JA; Schipper MJ; Shewach DS; Pierce LJ
    Breast J; 2004; 10(3):204-10. PubMed ID: 15125746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
    Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.